EDSA
Edesa Biotech Inc
Halal Rating :
Last Price
$1.79
Last updated:
Market Cap
-
7D Change
3.47%
1 Year Change
-60.15%
Company Overview
Industries
Exchange
Next Earnings Date
Edesa Biotech Inc is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases. The company's main product candidate is EB05, which is being developed as a potential treatment for Acute Respiratory Distress Syndrome (ARDS). The company is currently in the research and development phase and does not generate revenue from product sales.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Edesa Biotech Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.